Interstitial Lung Disease

This information is useful for adults
Why Yale Medicine? 
  • Founded in 1997, the Interstitial Lung Disease (ILD) Program is an internationally recognized center of excellence.
  • An interdisciplinary team provides high-quality care through decades of combined experience.
  • Doctors within the program collaborate on cases with physicians around the country.

Interstitial lung disease (ILD) refers to a group of diseases that irritate, inflame or scar the lungs and supporting air sacs. When this scarring (or pulmonary fibrosis) occurs, it can cause stiffness in the lungs, making it difficult for a person to breathe enough oxygen into the bloodstream.

Yale Medicine’s Interstitial Lung Disease Program focuses on bringing together specialists from different disciplines, including pulmonary pathologists, chest radiologists, rheumatologists and occupational medicine physicians, to provide patients with the best care. 

Interstitial lung disease refers to a group of more than 200 lung disorders. These can be caused by breathing in dangerous particles (such as from occupational exposure to fumes, gases, or molds) or dust in the air. The condition can also be set off by autoimmune disease, medication and some types of radiation. Other cases may be caused by inherited genes. Physicians at Yale also see patients with sarcoidosis, a type of lung disease that causes lumps to develop in the lungs and lymph nodes. When the disease develops for unknown reasons, it is called idiopathic pulmonary fibrosis.